#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fallopian tube cancer Biliary neoplasm Restless legs syndrome Adenoid cystic carcinoma Intracranial germ cell tumour Fabry's disease Head and neck cancer Oesophageal adenocarcinoma Infective uveitis Aicardi-Goutieres syndrome Vascular calcification Lymphatic malformation Follicle centre lymphoma follicular grade I II – III refractory Acute graft versus host disease in skin IgA nephropathy More trials…

    Learn about Rare Diseases

    Factor IX deficiency – Life with Disease Turner’s syndrome – Trials in Disease Congenital nephrogenic diabetes insipidus – Basic Information Hypereosinophilic syndrome – Diagnostics Hepatoblastoma – Life with Disease Adrenocortical carcinoma Adrenogenital syndrome – Diagnostics Bronchiolitis obliterans syndrome – Life with Disease Hairy cell leukaemia recurrent – Life with Disease Mantle cell lymphoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Istem-01 Insulin Human (Rdna) NIZUBAGLUSTAT Jnj-77242113 Cimetidine Hydrochloride VIPOGLANSTAT Leniolisib Phosphate Microcrystalline Cellulose Lurasidone Gskvx000000008885 Garadacimab Nido-361 Idecabtagene Vicleucel LY3537021 Epinephrine Mosunetuzumab Levoleucovorin HAFNIUM OXIDE Ipatasertib Ethambutol Hydrochloride More therapies…

    Learn about Your Condition

    Substance use disorder Bladder cancer stage II Renal cancer Femoral neck fracture Weaning failure Myasthenia gravis Optic atrophy Right ventricular dysfunction Primary hyperaldosteronism Metabolic syndrome Spondylolisthesis Small intestine adenocarcinoma Bacterial vaginosis Kearns-Sayre syndrome Oedema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Non-small cell lung cancer metastatic

  • Study on IO102-IO103 and Pembrolizumab for Patients with Metastatic Lung, Head and Neck, or Bladder Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma stage IV
    • Non-small cell lung cancer metastatic
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Io103 Acetate
    • Pembrolizumab
    Spain

  • Study Comparing Subcutaneous and Intravenous Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of lung
    • Non-small cell lung cancer stage IV
    • Non-small cell lung cancer
    Investigated Drugs:
    • Pemetrexed Disodium
    • Carboplatin
    • Cisplatin
    France Hungary Poland Romania Spain

  • Study of Tiragolumab and Atezolizumab for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Not Had Chemotherapy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Atezolizumab
    • Tiragolumab
    France Spain

  • Study on the Safety and Effects of ATL001 and Pembrolizumab in Adults with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenosquamous cell lung cancer recurrent
    • Adenosquamous cell lung cancer stage III
    • Adenosquamous cell lung cancer stage IV
    Investigated Drugs:
    • Atl001
    • Pembrolizumab
    France Germany Spain

  • Study on PF-07220060, Letrozole, and Fulvestrant for Patients with Advanced Breast Cancer, Prostate Cancer, and Other Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Pf-07220060 Monohydrate
    • Letrozole
    • Fulvestrant
    Czechia Slovakia

  • Study Comparing Lorlatinib and Crizotinib for Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IV
    • Non-small cell lung cancer
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Lorlatinib
    Belgium Czechia France Germany Italy The Netherlands +2
Previous Page
1 … 9 10 11 12 13 14
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!